Cargando…

Mood dysregulation

The publication of the DSM-5 is nearing, yet a debate continues about the boundaries of bipolar disorder (BP) in children and adolescents. This article focuses on two key components of this debate that are often treated under the collective term mood dysregulation: the first is chronic irritability...

Descripción completa

Detalles Bibliográficos
Autores principales: Mikita, Nina, Stringaris, Argyris
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer-Verlag 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3560944/
https://www.ncbi.nlm.nih.gov/pubmed/23229139
http://dx.doi.org/10.1007/s00787-012-0355-9
_version_ 1782257875213615104
author Mikita, Nina
Stringaris, Argyris
author_facet Mikita, Nina
Stringaris, Argyris
author_sort Mikita, Nina
collection PubMed
description The publication of the DSM-5 is nearing, yet a debate continues about the boundaries of bipolar disorder (BP) in children and adolescents. This article focuses on two key components of this debate that are often treated under the collective term mood dysregulation: the first is chronic irritability (and the proposed DSM-5 category of disruptive mood dysregulation disorder) and the other concerns short episodes of mania-like symptoms. We update our previous review [Stringaris in Eur Child Adolesc Psychiatry 20(2):61–66, 2011] and also present relevant neurobiological evidence. Most findings so far suggests that chronic, severe irritability is not a developmental presentation of mania. The diagnostic status of brief duration hypomania is less clear, with some evidence in support of its clinical relevance to BP. We end with recommendations for future research to inform classification and treatment.
format Online
Article
Text
id pubmed-3560944
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher Springer-Verlag
record_format MEDLINE/PubMed
spelling pubmed-35609442013-02-01 Mood dysregulation Mikita, Nina Stringaris, Argyris Eur Child Adolesc Psychiatry Review The publication of the DSM-5 is nearing, yet a debate continues about the boundaries of bipolar disorder (BP) in children and adolescents. This article focuses on two key components of this debate that are often treated under the collective term mood dysregulation: the first is chronic irritability (and the proposed DSM-5 category of disruptive mood dysregulation disorder) and the other concerns short episodes of mania-like symptoms. We update our previous review [Stringaris in Eur Child Adolesc Psychiatry 20(2):61–66, 2011] and also present relevant neurobiological evidence. Most findings so far suggests that chronic, severe irritability is not a developmental presentation of mania. The diagnostic status of brief duration hypomania is less clear, with some evidence in support of its clinical relevance to BP. We end with recommendations for future research to inform classification and treatment. Springer-Verlag 2012-12-11 2013 /pmc/articles/PMC3560944/ /pubmed/23229139 http://dx.doi.org/10.1007/s00787-012-0355-9 Text en © The Author(s) 2012 https://creativecommons.org/licenses/by/2.0/ Open AccessThis article is distributed under the terms of the Creative Commons Attribution License which permits any use, distribution, and reproduction in any medium, provided the original author(s) and the source are credited.
spellingShingle Review
Mikita, Nina
Stringaris, Argyris
Mood dysregulation
title Mood dysregulation
title_full Mood dysregulation
title_fullStr Mood dysregulation
title_full_unstemmed Mood dysregulation
title_short Mood dysregulation
title_sort mood dysregulation
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3560944/
https://www.ncbi.nlm.nih.gov/pubmed/23229139
http://dx.doi.org/10.1007/s00787-012-0355-9
work_keys_str_mv AT mikitanina mooddysregulation
AT stringarisargyris mooddysregulation